Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles from the last 7 days matching "multiple sclerosis"

AdvocacyRSS2 days ago

Take It From a Patient With MS: Hit It Fast and Hit It Hard

A patient with MS shares their personal experience of why starting treatment quickly with the most powerful available medications is worth it to them. They believe the benefits of aggressive, early treatment outweigh the potential side effects. This is one patient's perspective on MS treatment strategy.

WHY IT MATTERSThis patient perspective highlights the real-world decision-making that people with MS face when choosing between starting strong treatments early versus waiting, which can help other newly diagnosed patients think through their own treatment conversations.
💬 Ask your doctorMultiple SclerosisRead →
Clinical trialRSS2 days ago

How an EBV Vaccine Could Be a Major MS Disrupter

Scientists are testing a new vaccine against Epstein-Barr virus (EBV), a common virus that may trigger multiple sclerosis (MS). Early research suggests that preventing EBV infection could help prevent or reduce MS development. This vaccine could be a major breakthrough for people at risk of developing MS or those already living with the disease.

WHY IT MATTERSIf successful, an EBV vaccine could prevent MS from developing in the first place, offering a potential cure-like approach rather than just managing symptoms after diagnosis.
👁 Watch this spacemultiple sclerosisRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases